AC Immune shares jumped more than 50% premarket on Monday after the company announced a licensing deal with Takeda Pharmaceutical Co. for its experimental Alzheimer’s disease vaccine.
[stock-market-ticker symbols="AAPL;MSFT;GOOG;HPQ;^SPX;^DJI;LSE:BAG" stockExchange="NYSENasdaq" width="100%" palette="financial-light"]
